Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

House Panel Passes Protection For Drug Makers
The House Energy and Commerce Committee passed an amendment to their broad health reform bill giving drug makers 12 years of exclusive rights to market new biologic drugs, "a setback" to the administration and consumer advocates who hoped to make generic drugs more widely available, the Wall Street Journal reports. The panel voted 47-11 on the measure, which "would also allow "evergreening," the practice by pharmaceutical companies of making minimal adjustments to their drugs, such as creating extended-release versions, as a way to lengthen their monopoly."
generic viagra online
Nicotine Dependence Remains Prevalent Despite Recent Declines In Cigarette Use
Despite recent declines in cigarette use in the U.S., nicotine dependence has remained steady among adults and has actually increased among some groups. The finding by researchers at Columbia University Mailman School of Public Health suggests that public health initiatives have been far more successful in preventing Americans from taking up smoking than in persuading hard-core smokers to stop. The study is available online in the American Journal of Public Health and will be published in the August 2009 issue.
News of the day
New Study Highlights Threat Of Resistance To Artemisinin-Based Anti-Malarial Drugs
Malaria parasites in western Cambodia have become resistant to artemisinin-based therapies, the first-line treatment for malaria, according to a study published in the New England Journal of Medicine. Resistance to the drugs makes them less effective and could eventually render them obsolete, putting millions of lives at risk.
Diagnostics

New DNA Sequencers To Speed Up Research, Australia

The time it takes to map a single human genome could be radically reduced thanks to two new next generation DNA sequencers to be unveiled at The John Curtin School of Medical Research (JCSMR) at The Australian National University tomorrow. The new machines will be markedly more powerful and faster than traditional sequencers reducing the time it takes to sequence a single human genome from 12 years to about 30 days. Because of reductions in time and cost, sequencing is likely to become the platform of choice for a greater variety of applications in areas such as infection and immunity; ecology, environment and evolution; genes and proteins and plant sciences. The sequencers, an Illumina GAIIx and a Roche GSFLX, are worth around $1.3 million. Funding for the equipment was from an ARC-LIEF grant jointly submitted by The Australian National University, The University of Canberra, CSIRO Plant Industry and CSIRO Entomology as well as financial contributions from each organisation. The sequencers will be housed at the Australian Cancer Research Foundation Biomolecular Re Facility in The John Curtin School of Medical Research at ANU and be available for use by researchers from all institutions. These sequencers will play an important role in advancing cutting-edge research with important health, agricultural and environmental applications. Professor Frances Shannon, Director JCSMR (ANU), Dr Liz Dennis, Chief Research Scientist (CSIRO Plant Industry) and Professor Arthur Georges, Dean of Applied Science (UC) will unveil the sequencers at the launch. The Australian National University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009